Johnson Chemical Pharmaceutical Works Co., Ltd. logo

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
56. 10
+2
+3.6969%
NT$
3B Market Cap
- P/E Ratio
5.99% Div Yield
99,267 Volume
- Eps
NT$ 54.1
Previous Close
Add Transaction
Day Range
52.2 58.1
Year Range
45.1 80.4
Want to track 4747 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Upcoming 4747 split of 2:1 in 9 days (20 Aug 2026)

Summary

4747 closed today higher at NT$56.1, an increase of 3.6969% from yesterday's close, completing a monthly increase of 13.4479% or NT$6.65. Over the past 12 months, 4747 stock lost -6.8106%.
4747 pays dividends to its shareholders, with the most recent payment made on Jul 29, 2026. The next estimated payment will be in In 11 months on Jul 29, 2027 for a total of NT$1.05.
Johnson Chemical Pharmaceutical Works Co., Ltd. has a scheduled stock split on Aug 20, 2026 for a 2:1 split ratio, meaning every 4747 investor will receive 2.0 shares for every 1.0 existing shares.
Johnson Chemical Pharmaceutical Works Co., Ltd. has completed 8 stock splits, with the recent split occurring on Jun 12, 2023.
The company's stock is traded on one exchange.

4747 Chart

People also search for

Nak Sealing Technologies Corp.
NT$ 117.5
-0.8439%
Federal Corporation
NT$ 18.8
+0.8043%
YC Co., Ltd.
NT$ 14.3
-0.6944%
Sampo Corporation
NT$ 23.25
+0.2155%
Power Wind Health Industry Co. Ltd.
NT$ 169.5
-1.1662%

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) FAQ

What is the stock price today?

The current price is NT$56.10.

On which exchange is it traded?

Johnson Chemical Pharmaceutical Works Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4747.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5.99%.

What is its market cap?

As of today, the market cap is 3B.

Has Johnson Chemical Pharmaceutical Works Co., Ltd. ever had a stock split?

Johnson Chemical Pharmaceutical Works Co., Ltd. had 8 splits and the recent split was on Jun 12, 2023.

Johnson Chemical Pharmaceutical Works Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Baixiong Huang CEO
TWSE Exchange
TW0004747001 ISIN
Taiwan Country
171 Employees
6 Jul 2026 Last Dividend
20 Aug 2026 Last Split
- IPO Date

Overview

Johnson Chemical Pharmaceutical Works Co., Ltd., established in 1959 and located in New Taipei City, Taiwan, is a notable entity in the pharmaceutical sector. The company is engaged in manufacturing, importing, and selling a wide range of pharmaceutical ingredients, materials, and products. With a lengthy history, it has established itself as a reliable source in the healthcare industry, providing solutions across various therapeutic areas to meet the diverse needs of healthcare providers and patients alike. Its commitment to quality and innovation is evidenced by its product offerings and continuous growth in the pharmaceutical industry.

Products and Services

  • Central Nervous System:

    Johnson Chemical Pharmaceutical Works Co., Ltd. offers medications that target the central nervous system, catering to conditions such as anxiety, depression, and other neurological disorders. These products aim to improve patient quality of life by stabilizing mood and increasing nerve function.

  • Respiratory:

    Products designed for the respiratory system are developed to treat conditions like asthma, chronic obstructive pulmonary disease (COPD), and allergies. These include inhalers, nebulizers, and oral medications that help to relieve symptoms and improve breathing.

  • Cardiovascular:

    The company provides a variety of cardiovascular drugs intended for the treatment of heart-related conditions. These medicines are vital in managing hypertension, heart failure, and preventing heart attacks and strokes.

  • Gastrointestinal:

    For gastrointestinal health, the company offers products that treat a range of conditions from acid reflux and ulcers to irritable bowel syndrome (IBS). These ensure better digestive health and comfort for patients.

  • Endocrine System:

    Focusing on the endocrine system, their products include treatments for diabetes, thyroid disorders, and other hormone-related conditions, playing a crucial role in managing these lifelong conditions.

  • Vitamin:

    The vitamin category covers a broad spectrum of dietary supplements and vitamin-enriched products designed to support overall health and wellness, catering to the nutritional needs of diverse patient groups.

  • Anti-inflammatory:

    Anti-inflammatory medications are offered to treat various conditions that cause inflammation and pain, such as arthritis and other musculoskeletal disorders, providing relief and improving patient mobility.

  • Cough and Cold:

    The range of cough and cold products addresses symptoms of the common cold, flu, and other respiratory infections, helping to alleviate discomfort and promote faster recovery.

  • Pain Reliever:

    Pain relievers from Johnson Chemical Pharmaceutical Works Co., Ltd. address a wide range of pain types, from mild headaches to more severe pain, ensuring effective pain management for patients.

  • Forms:

    The company provides its medical solutions in various forms, including solid dosage, capsule, tablet, powder and granule, and nasal spray forms to cater to different patient preferences and needs.

Contact Information

Address: No. 77 and No.79, Sanhe Road
Phone: 886 2 2989 4756